(PharmaNewsWire.Com, January 11, 2017 ) According to the report Safety Syringes Market by Technology, by Therapy, by End Users and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (20162021)", published by Market Data Forecast, the global market is projected to reach USD 7095 million by 2021, at a CAGR of 8.96% from 2016 to 2021.
Injection practices worldwide, particularly in low- and middle-income countries (LMICs) include multiple, preventable unsafe practices that ultimately lead to large scale transmission of blood-borne viruses among patients, health-care providers and the community at large. Safety syringes are specifically designed to eradicate this situation and protect healthcare workers and others from accidental needle-stick injuries, which will subsequently protect the hospital professions from healthcare-acquired infections.
Of late, governments have issued legislation to ensure compulsory use of safety syringes to reduce needle stick injuries and also prevent needle re-use. With the introduction of these legislations there has been an increased use of safety syringes than conventional syringes in recent times. Further, increase in the frequency of needle stick injuries, growing injectable market and rising demand for safety mechanisms in syringes are thrusting the growth of global safety syringe market.
Some of the major companies functioning in the global safety syringes market are Covidien plc, Terumo Corporation, Becton, Dickinson & Company, Unilife Corporation, Revolutions Medical Corporation, Smiths Medical, Sol-Millennum, Ultimed, Inc., Axel Bio Corporation and Retractable Technologies, Inc.
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: